A rare, non-intoxicating compound that originates as cannabichromenic acid (CBCA) then converts to cannabicyclolic acid (CBLA) when cannabis is exposed to natural environmental changes during storage. CBLA has been studied for its anti-inflammatory properties, among other potential benefits.
Studies show that cannabicyclolic acid (CBLA) reduces inflammation.
Cannabicyclolic acid (CBLA) comes from another compound's degradation.